Indian-origin Hedge Fund Manager

An Indian-origin CEO was sentenced to over four years in prison after being convicted of securities fraud for his participation in a scheme to inflate the net asset value for hedge funds managed by the company by over USD 100 million.

An Indian-origin founder of a Manhattan-based hedge fund firm and a former trader of the enterprise have been found guilty of securities fraud for their participation in a scheme to inflate the net asset value for hedge funds managed by the company by over USD 100 million.

Sanjay Valvani, 44, was found unconscious on the bedroom floor at home in the upscale neighborhood of Brooklyn Heights with a slash wound to his neck late on Monday afternoon, a police spokesman told AFP.

An Indian-origin hedge fund manager charged last week with insider trading was found dead with a slashed neck in an apparent suicide, police said today.

A hedge fund manager of Indian origin has been charged with participating in a stock market insider trading scam involving generic drugs that allegedly netted him at least $25 million in profits, according to US authorities.

An Indian-origin hedge fund manager was today charged by the Securities and Exchange Commission with insider trading after he reaped unlawful profits of nearly $32 million by trading on pharma stocks on the basis of tips he received from a former US government official.

An Indian-origin former hedge fund portfolio manager will face trial in a federal court here for allegedly participating in one of the "most lucrative" insider trading schemes worth $276 million involving information about clinical trials for an Alzheimer's drug.

A former hedge fund portfolio manager accused of passing along information in one of the largest insider trading fraud cases in history appeared in a Manhattan court for the first time on Monday and was released on $5 million bail, though his movements were restricted.

An Indian-origin hedge fund portfolio manager will appear in Manhattan federal court after he was arrested last week and charged with participating in a $276 million insider trading scheme involving Alzheimer's disease drug trial.

An Indian-origin CEO was sentenced to over four years in prison after being convicted of securities fraud for his participation in a scheme to inflate the net asset value for hedge funds managed by the company by over USD 100 million.

An Indian-origin founder of a Manhattan-based hedge fund firm and a former trader of the enterprise have been found guilty of securities fraud for their participation in a scheme to inflate the net asset value for hedge funds managed by the company by over USD 100 million.

Sanjay Valvani, 44, was found unconscious on the bedroom floor at home in the upscale neighborhood of Brooklyn Heights with a slash wound to his neck late on Monday afternoon, a police spokesman told AFP.

An Indian-origin hedge fund manager charged last week with insider trading was found dead with a slashed neck in an apparent suicide, police said today.

A hedge fund manager of Indian origin has been charged with participating in a stock market insider trading scam involving generic drugs that allegedly netted him at least $25 million in profits, according to US authorities.

An Indian-origin hedge fund manager was today charged by the Securities and Exchange Commission with insider trading after he reaped unlawful profits of nearly $32 million by trading on pharma stocks on the basis of tips he received from a former US government official.

An Indian-origin former hedge fund portfolio manager will face trial in a federal court here for allegedly participating in one of the "most lucrative" insider trading schemes worth $276 million involving information about clinical trials for an Alzheimer's drug.

A former hedge fund portfolio manager accused of passing along information in one of the largest insider trading fraud cases in history appeared in a Manhattan court for the first time on Monday and was released on $5 million bail, though his movements were restricted.

An Indian-origin hedge fund portfolio manager will appear in Manhattan federal court after he was arrested last week and charged with participating in a $276 million insider trading scheme involving Alzheimer's disease drug trial.